NFKB1 and neoplasm: Moreover, BV resistance could be related to many other factors, such as intrinsic resistance to MMAE or to antibody–drug conjugates [40], increased NF-kB activation [41], CD30 shedding by metalloproteinases expressed by tumor cells or by other cells of the TME [14].